Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Circulating tumor cell"" wg kryterium: Temat


Tytuł :
A Novel System to Detect Circulating Tumor Cells Using Two Different Size-selective Microfilters.
Autorzy :
Sonoda T; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Yanagitani N; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Suga K; Division of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yoshizawa T; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Internal Medicine, Division of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan.
Nishikawa S; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Respiratory Medicine, Kanazawa University Hospital, Ishikawa, Japan.
Kitazono S; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Horiike A; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Shiba K; Division of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ishizuka T; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Nishio M; Department of Thoracic Medical Oncology, the Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Matsusaka S; Division of Protein Engineering, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan .; Clinical Research and Regional Innovation, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Oct; Vol. 40 (10), pp. 5577-5582.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung/*blood
Circulating Tumor DNA/*blood
Epithelial Cell Adhesion Molecule/*blood
Neoplastic Cells, Circulating/*metabolism
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Separation ; Female ; Humans ; Liquid Biopsy ; Male ; Middle Aged ; Mutation/genetics ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Tytuł :
Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.
Autorzy :
Mentis AA; Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.; Department of Microbiology, University Hospital of Thessaly, Larissa, Greece.
Grivas PD; Division of Oncology, Department of Medicine, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Dardiotis E; Department of Neurology, University Hospital of Thessaly, Larissa, Greece.
Romas NA; Department of Urology, Columbia University Medical Center, Vagelos College of Physicians and Surgeons, New York, NY, USA.
Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 M. Asias Street-Bldg. 16, 11527, Athens, Greece. .
Pokaż więcej
Źródło :
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2020 Sep; Vol. 77 (18), pp. 3671-3690. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Neoplasms/*pathology
Neoplastic Cells, Circulating/*metabolism
Circulating Tumor DNA/metabolism ; Epithelial Cell Adhesion Molecule/metabolism ; Epithelial-Mesenchymal Transition ; Humans ; Liquid Biopsy ; Neoplasm Micrometastasis ; Neoplasms/therapy ; Neoplastic Cells, Circulating/pathology ; Prognosis ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
Autorzy :
Moon SM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
Kim JH; EDGC, Inc., Incheon, Republic of Korea.
Kim SK; CytoGen Inc., Seoul, Republic of Korea.
Kim S; Statistics and Data Center, Samsung Medical Center, Seoul, Republic of Korea.
Kwon HJ; EDGC, Inc., Incheon, Republic of Korea.
Bae JS; EDGC, Inc., Incheon, Republic of Korea.
Lee S; EDGC, Inc., Incheon, Republic of Korea.
Lee HS; CytoGen Inc., Seoul, Republic of Korea.
Choi MY; CytoGen Inc., Seoul, Republic of Korea.
Jeon BH; CytoGen Inc., Seoul, Republic of Korea.
Jeong BH; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Um SW; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Jun; Vol. 40 (6), pp. 3435-3444.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*
Circulating Tumor DNA*
DNA, Neoplasm*/blood
Lung Neoplasms/*diagnosis
Lung Neoplasms/*etiology
Neoplastic Cells, Circulating/*pathology
Aged ; Aged, 80 and over ; Disease Susceptibility ; Female ; Humans ; Liquid Biopsy ; Male ; Middle Aged ; Neoplasm Staging ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł :
Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
Autorzy :
Tada H; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Takahashi H; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Ida S; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Nagata Y; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Chikamatsu K; Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Jun; Vol. 40 (6), pp. 3559-3564.
Typ publikacji :
Journal Article
MeSH Terms :
Epithelial-Mesenchymal Transition*/genetics
Neoplastic Cells, Circulating/*pathology
Squamous Cell Carcinoma of Head and Neck/*genetics
Squamous Cell Carcinoma of Head and Neck/*pathology
Biomarkers, Tumor ; Cell Line, Tumor ; Female ; Gene Expression ; Gene Expression Profiling ; Humans ; Immunophenotyping ; Male ; Neoplasm Recurrence, Local ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/mortality
Czasopismo naukowe
Tytuł :
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer.
Autorzy :
Banys-Paluchowski M; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany.
Fehm T; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Neubauer H; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Paluchowski P; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Krawczyk N; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Meier-Stiegen F; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Wallach C; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Kaczerowsky A; Department of Gynecology and Obstetrics, Marienkrankenhaus Hamburg, Alfredstr. 9, 22087, Hamburg, Germany.
Gebauer G; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany. .
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Apr; Vol. 301 (4), pp. 1027-1035. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*blood
Fallopian Tube Neoplasms/*physiopathology
Neoplastic Cells, Circulating/*pathology
Ovarian Neoplasms/*physiopathology
Peritoneal Neoplasms/*physiopathology
Fallopian Tube Neoplasms/mortality ; Female ; Humans ; Ovarian Neoplasms/mortality ; Peritoneal Neoplasms/mortality ; Prognosis ; Prospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
3D printed microfluidic devices for circulating tumor cells (CTCs) isolation.
Autorzy :
Chen J; Department of Mechanical Engineering, University of California, Berkeley, USA; Berkeley Sensor and Actuators Center, USA; Department of Biological Systems Engineering, Virginia Tech, USA; Hangzhou Institute of Advanced Transducing Technology, Wahaha R&D Academe, Hangzhou, China. Electronic address: .
Liu CY; School of Optometry and Vision Science Program, University of California, Berkeley, USA; Department of Materials Science and Engineering, National Cheng Kung University, Tainan, Taiwan.
Wang X; Department of Mechanical Engineering, University of California, Berkeley, USA; School of Mechanical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Sweet E; Department of Mechanical Engineering, University of California, Berkeley, USA; Berkeley Sensor and Actuators Center, USA.
Liu N; Department of Mechanical Engineering, University of California, Berkeley, USA.
Gong X; School of Optometry and Vision Science Program, University of California, Berkeley, USA.
Lin L; Department of Mechanical Engineering, University of California, Berkeley, USA; Berkeley Sensor and Actuators Center, USA. Electronic address: .
Pokaż więcej
Źródło :
Biosensors & bioelectronics [Biosens Bioelectron] 2020 Feb 15; Vol. 150, pp. 111900. Date of Electronic Publication: 2019 Nov 16.
Typ publikacji :
Journal Article
MeSH Terms :
Lab-On-A-Chip Devices*
Cell Separation/*instrumentation
Neoplastic Cells, Circulating/*pathology
Antibodies, Immobilized/chemistry ; Biosensing Techniques/instrumentation ; Equipment Design ; Humans ; Neoplasms/blood ; Neoplasms/pathology ; Neoplastic Cells, Circulating/chemistry ; Printing, Three-Dimensional
Czasopismo naukowe
Tytuł :
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib.
Autorzy :
Matsusaka S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Clinical Research and Regional Innovation, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Hanna DL; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Ning Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Yang D; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Cao S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Berger MD; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Miyamoto Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Suenaga M; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Dan S; Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Mashima T; Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Seimiya H; Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2020 Feb; Vol. 111 (2), pp. 441-450. Date of Electronic Publication: 2020 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Up-Regulation*
Colorectal Neoplasms/*drug therapy
Neoplastic Cells, Circulating/*drug effects
Phenylurea Compounds/*administration & dosage
Pyridines/*administration & dosage
Adult ; Aged ; Cell Count ; Colorectal Neoplasms/genetics ; Disease Progression ; Drug Resistance, Neoplasm ; Epithelial-Mesenchymal Transition ; ErbB Receptors/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplastic Cells, Circulating/metabolism ; Phenylurea Compounds/pharmacology ; Prognosis ; Prospective Studies ; Pyridines/pharmacology ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical Applications of Circulating Tumor Cells in Breast Cancer.
Autorzy :
Cobain EF; Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA.
Paoletti C; Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA.
Smerage JB; Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA.
Hayes DF; Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA. .
Pokaż więcej
Źródło :
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer [Recent Results Cancer Res] 2020; Vol. 215, pp. 147-160.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Breast Neoplasms/*pathology
Neoplasm Metastasis/*pathology
Neoplastic Cells, Circulating/*pathology
Humans
Czasopismo naukowe
Tytuł :
Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
Autorzy :
Yu Y; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Lin ZX; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Li HW; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Luo HQ; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Yang DH; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Zhou HC; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Jiang DX; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Zhan DC; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Yang L; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Liang XY; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Yu ZH; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Chen ZH; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Pokaż więcej
Źródło :
Technology in cancer research & treatment [Technol Cancer Res Treat] 2020 Jan-Dec; Vol. 19, pp. 1533033820909911.
Typ publikacji :
Journal Article
MeSH Terms :
Fibronectins/*biosynthesis
Nasopharyngeal Carcinoma/*blood
Nasopharyngeal Carcinoma/*pathology
Nasopharyngeal Neoplasms/*blood
Nasopharyngeal Neoplasms/*pathology
Neoplastic Cells, Circulating/*metabolism
Adult ; Aged ; Aged, 80 and over ; Female ; Fibronectins/genetics ; Fibronectins/metabolism ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Neoplasms/genetics ; Neoplastic Cells, Circulating/pathology ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Young Adult
Czasopismo naukowe
Tytuł :
An update: circulating tumor cells in head and neck cancer.
Autorzy :
Kulasinghe A; Saliva and Liquid Biopsy Translational Research Team, The School of Biomedical, Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia.; Translational Research Institute, Brisbane, Australia.
Hughes BGM; Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.; University of Queensland, Australia.
Kenny L; Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.; University of Queensland, Australia.; Queensland Health, Central Integrated Regional Cancer Services.
Punyadeera C; Saliva and Liquid Biopsy Translational Research Team, The School of Biomedical, Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia.; Translational Research Institute, Brisbane, Australia.
Pokaż więcej
Źródło :
Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2019 Dec; Vol. 19 (12), pp. 1109-1115. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Biomarkers, Tumor/*immunology
Carcinoma, Squamous Cell/*diagnosis
Head and Neck Neoplasms/*diagnosis
Neoplastic Cells, Circulating/*immunology
Biomarkers, Tumor/blood ; Carcinoma, Squamous Cell/blood ; Carcinoma, Squamous Cell/therapy ; Head and Neck Neoplasms/blood ; Head and Neck Neoplasms/therapy ; Humans ; Immunotherapy
Czasopismo naukowe
Tytuł :
High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications.
Autorzy :
Chen J; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Chen L; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Du S; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China.
Wu J; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Quan M; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Yin H; Department of Gastrointestinal Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Wu Y; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Ye X; Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Datong Rd, Shanghai, 200137, People's Republic of China.
Liang X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200032, China. .
Jiang H; Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Datong Rd, Shanghai, 200137, People's Republic of China. .; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. .
Pokaż więcej
Źródło :
Journal of nanobiotechnology [J Nanobiotechnology] 2019 Nov 25; Vol. 17 (1), pp. 116. Date of Electronic Publication: 2019 Nov 25.
Typ publikacji :
Journal Article
MeSH Terms :
Epithelial Cell Adhesion Molecule/*analysis
Magnetite Nanoparticles/*analysis
Neoplasms/*diagnosis
Neoplastic Cells, Circulating/*pathology
Animals ; Biomarkers, Tumor/analysis ; Cell Line, Tumor ; Cell Separation/methods ; Humans ; Neoplasms/blood
Czasopismo naukowe
Tytuł :
Analysis of colorectal cancer-related mutations by liquid biopsy: Utility of circulating cell-free DNA and circulating tumor cells.
Autorzy :
Takeda K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yamada T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Takahashi G; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Iwai T; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Ueda K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Kuriyama S; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Koizumi M; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Matsuda A; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Shinji S; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Ohta R; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yokoyama Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Hotta M; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Hara K; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Yoshida H; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2019 Nov; Vol. 110 (11), pp. 3497-3509. Date of Electronic Publication: 2019 Sep 18.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Mutation*
Cell-Free Nucleic Acids/*analysis
Colorectal Neoplasms/*genetics
DNA, Neoplasm/*analysis
Neoplastic Cells, Circulating/*chemistry
Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/pathology ; DNA Mutational Analysis ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy ; Male ; Middle Aged ; Polymerase Chain Reaction ; Prospective Studies ; Proto-Oncogene Proteins p21(ras)/genetics
Czasopismo naukowe
Tytuł :
Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential.
Autorzy :
Allen TA; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Asad D; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27607, USA.
Amu E; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Hensley MT; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Cores J; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27607, USA.
Vandergriff A; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27607, USA.
Tang J; Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450001, China.
Dinh PU; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Shen D; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Qiao L; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Su T; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27607, USA.
Hu S; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Liang H; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Shive H; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Harrell E; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Campbell C; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Peng X; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27607, USA.; Bioinformatics Graduate Program, North Carolina State University, Raleigh, NC 27607, USA.
Yoder JA; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA.
Cheng K; Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA .; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27607, USA.
Pokaż więcej
Źródło :
Journal of cell science [J Cell Sci] 2019 Sep 09; Vol. 132 (17). Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Cell Movement/*physiology
Neoplastic Cells, Circulating/*metabolism
Animals ; Cell Count ; HeLa Cells ; Humans ; Mice ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Metastatic Tumor Cells Exploit Their Adhesion Repertoire to Counteract Shear Forces during Intravascular Arrest.
Autorzy :
Osmani N; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Follain G; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
García León MJ; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Lefebvre O; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Busnelli I; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Larnicol A; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France.
Harlepp S; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France. Electronic address: .
Goetz JG; INSERM UMR_S1109, Tumor Biomechanics, Strasbourg 67000, France; Université de Strasbourg, Strasbourg 67000, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg 67000, France. Electronic address: .
Pokaż więcej
Źródło :
Cell reports [Cell Rep] 2019 Sep 03; Vol. 28 (10), pp. 2491-2500.e5.
Typ publikacji :
Journal Article
MeSH Terms :
Stress, Mechanical*
Neoplasms/*pathology
Neoplastic Cells, Circulating/*pathology
Animals ; Cell Adhesion ; Cell Line, Tumor ; Embryo, Nonmammalian/pathology ; Female ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Integrins/metabolism ; Lung Neoplasms/secondary ; Mice, Inbred BALB C ; Neoplasm Metastasis ; Neoplastic Cells, Circulating/metabolism ; Zebrafish/embryology
Czasopismo naukowe
Tytuł :
Silent mating-type information regulation 2 homolog 1 overexpression is an important strategy for the survival of adapted suspension tumor cells.
Autorzy :
Park JY; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Han S; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Ka HI; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Joo HJ; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Soh SJ; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Yoo KH; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Yang Y; Department of Biological Sciences, Research Center for Cellular Heterogeneity, Research Institute of Women's Health, Sookmyung Women's University, Seoul, Korea.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2019 Sep; Vol. 110 (9), pp. 2773-2782. Date of Electronic Publication: 2019 Aug 11.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Survival*
Breast Neoplasms/*pathology
Neoplastic Cells, Circulating/*pathology
Sirtuin 1/*metabolism
Animals ; Apoptosis ; Breast Neoplasms/blood ; Breast Neoplasms/genetics ; Cell Line, Tumor ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; NF-kappa B/metabolism ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells.
Autorzy :
Que Z; Oncology Institute of Traditional Chinese Medicine, Shanghai Research Institute of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China.
Zhou Z; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China.
Luo B; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China.
Dong C; Oncology Institute of Traditional Chinese Medicine, Shanghai Research Institute of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China.
Jiang Y; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China.
Li H; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China. .
Tian J; Oncology Institute of Traditional Chinese Medicine, Shanghai Research Institute of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China. .; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, No. 725, South Wanping Road, Shanghai, 200032, China. .
Pokaż więcej
Źródło :
BMC complementary and alternative medicine [BMC Complement Altern Med] 2019 Aug 07; Vol. 19 (1), pp. 204. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Phytogenic/*pharmacology
Carcinoma, Non-Small-Cell Lung/*genetics
DNA Damage/*drug effects
Drugs, Chinese Herbal/*pharmacology
Neoplastic Cells, Circulating/*drug effects
Oxidative Stress/*drug effects
Apoptosis/drug effects ; Ataxia Telangiectasia Mutated Proteins/genetics ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/physiopathology ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Humans ; Neoplastic Cells, Circulating/metabolism ; Reactive Oxygen Species/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
Czasopismo naukowe
Tytuł :
Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
Autorzy :
Onidani K; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Shoji H; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Kakizaki T; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.
Yoshimoto S; Department of Head and Neck Surgery, National Cancer Center Central Hospital, Tokyo, Japan.
Okaya S; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.
Miura N; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.
Sekikawa S; Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Furuta K; Division of Clinical Laboratory, Kanagawa Cancer Center, Kanagawa, Japan.
Lim CT; Department of Biomedical Engineering, National University of Singapore, Singapore.; Biomedical Institute of Global Health Research and Technology, National University of Singapore, Singapore.; Mechanbiology Institute, National University of Singapore, Singapore, Singapore.
Shibahara T; Department of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Boku N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Kato K; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Honda K; Department of Biomarkers for Early Detection of Cancer, National Cancer Center Research Institute, Tokyo, Japan.; Japan Agency for Medical Research and Development (AMED) CREST, Tokyo, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2019 Aug; Vol. 110 (8), pp. 2590-2599. Date of Electronic Publication: 2019 Jul 23.
Typ publikacji :
Journal Article
MeSH Terms :
Circulating Tumor DNA/*genetics
DNA, Neoplasm/*genetics
Neoplasms/*genetics
Neoplasms/*pathology
Neoplastic Cells, Circulating/*pathology
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Epithelial Cell Adhesion Molecule/genetics ; Epithelial-Mesenchymal Transition/genetics ; ErbB Receptors/genetics ; Female ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Liquid Biopsy/methods ; Male ; Middle Aged ; Mutation/genetics
Czasopismo naukowe
Tytuł :
Choline-deficient-diet Decreases Fibroblasts in the Circulating Tumor Cell (CTC) Microenvironment.
Autorzy :
Matsuura K; Gifu University Graduate School of Medicine, Gifu, Japan.
Suetsugu A; Gifu University Graduate School of Medicine, Gifu, Japan .; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Satake T; Gifu University Graduate School of Medicine, Gifu, Japan.
Nakamura M; Gifu University Graduate School of Medicine, Gifu, Japan.
Kunisada T; Gifu University Graduate School of Medicine, Gifu, Japan.
Shimizu M; Gifu University Graduate School of Medicine, Gifu, Japan.
Hoffman RM; AntiCancer, Inc., San Diego, CA, U.S.A. .; Department of Surgery, University of California, San Diego, CA, U.S.A.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2019 Aug; Vol. 39 (8), pp. 4061-4064.
Typ publikacji :
Journal Article
MeSH Terms :
Choline/*metabolism
Lymphoma/*blood
Neoplastic Cells, Circulating/*metabolism
Stromal Cells/*metabolism
Animals ; Cell Line, Tumor ; Choline Deficiency/blood ; Choline Deficiency/genetics ; Choline Deficiency/pathology ; Diet/adverse effects ; Disease Models, Animal ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Green Fluorescent Proteins/chemistry ; Humans ; Luminescent Proteins/chemistry ; Lymphoma/genetics ; Lymphoma/pathology ; Mice ; Mice, Transgenic ; Neoplasm Metastasis ; Neoplastic Cells, Circulating/pathology ; Stromal Cells/pathology ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł :
Fluorescence monitoring of rare circulating tumor cell and cluster dissemination in a multiple myeloma xenograft model in vivo.
Autorzy :
Patil R; Northeastern University, Department of Bioengineering, Boston, Massachusetts, United States.
Tan X; Northeastern University, Department of Electrical and Computer Engineering, Boston, Massachusetts, United States.
Bartosik P; Northeastern University, Department of Bioengineering, Boston, Massachusetts, United States.
Detappe A; Dana Farber Cancer Institute, Harvard Medical School, Department of Medical Oncology, Boston, Massac, United States.
Runnels JM; Massachusetts General Hospital and Harvard Medical School, Center for Systems Biology and Wellman Ce, United States.
Ghobrial I; Dana Farber Cancer Institute, Harvard Medical School, Department of Medical Oncology, Boston, Massac, United States.
Lin CP; Massachusetts General Hospital and Harvard Medical School, Center for Systems Biology and Wellman Ce, United States.
Niedre M; Northeastern University, Department of Bioengineering, Boston, Massachusetts, United States.; Northeastern University, Department of Electrical and Computer Engineering, Boston, Massachusetts, United States.
Pokaż więcej
Źródło :
Journal of biomedical optics [J Biomed Opt] 2019 Aug; Vol. 24 (8), pp. 1-11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Microscopy, Confocal*
Neoplastic Cells, Circulating*
Multiple Myeloma/*blood
Multiple Myeloma/*diagnostic imaging
Animals ; Fluorescence ; Green Fluorescent Proteins/metabolism ; Humans ; Kinetics ; Male ; Mice ; Mice, SCID ; Mice, Transgenic ; Neoplasm Metastasis ; Neoplasm Transplantation ; Phantoms, Imaging
Czasopismo naukowe
Tytuł :
Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.
Autorzy :
Tong B; Lung Cancer Center, Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Chaoyao District, Beijing 100029, PR China.; Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, PR China.
Wang M; Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, PR China.; Lung Cancer Center, Department of Respiratory Medicine, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, PR China.
Pokaż więcej
Źródło :
Future oncology (London, England) [Future Oncol] 2019 Jul; Vol. 15 (21), pp. 2531-2542. Date of Electronic Publication: 2019 Jul 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lung Neoplasms/*diagnosis
Neoplastic Cells, Circulating/*pathology
Animals ; Biomarkers, Tumor ; Cell-Free Nucleic Acids ; DNA, Neoplasm ; Disease Management ; Early Detection of Cancer/methods ; Humans ; Lung Neoplasms/therapy ; Neoplastic Cells, Circulating/metabolism ; Precision Medicine/methods ; Prognosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies